|Application ||WB, IHC, E, DB|
|Other Names||Fasinex; Egaten|
|Reconstitution & Storage||Store at -20°C. Avoid freeze / thaw cycles. Short term storage +2°C-+8°C|
|Precautions||TRAZODONE Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Trazodone was originally discovered and developed in Italy in the 1960s by Angelini research laboratories as a second-generation antidepressant. It was developed according to the mental pain hypothesis, which was postulated from studying patients and which proposes that major depression is associated with a decreased pain threshold. . Trazodone also has anxiolytic, and hypnotic effects . Trazodone was patented and marketed in many countries all over the world. It was approved by the Food and Drug Administration (FDA) at the end of 1981.)
1. Haria M, Fitton A, McTavish D (April 1994). Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 4 (4): 331?55. doi:10.2165/00002512-199404040-00006. PMID 8019057
If you have any additional inquiries please email technical services at firstname.lastname@example.org.